Physician
Okpara, Nnenna
Okpara, Nnenna was paid $100K by Medicaid between Dec 2018 and Sep 2024, across 13 billing codes. Its largest line is 99211, Office or other outpatient visit for the evaluation and management of an established patient, minimal severity — 30% of everything it billed.
33Billing provider infoOKPARA, NNENNA
PROVIDENCE, RI 02905
PROVIDENCE, RI 02905
33aNPI1093813313assigned 09/20/2006
33bProvider typeInternal Medicine Physician
28Total paid$100K
24GClaims2,374
24DCodes billed13
24AFirst – last monthDec 2018 – Sep 2024
Compared with peers
Next to other Internal Medicine Physician providers in Rhode Island
Rank by total paid#79 of 386
Median peer was paid$15K
This provider vs. median6.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 59 | $1K | |
| 2019 | 29 | $686.05 | |
| 2020 | 472 | $17K | |
| 2021 | 794 | $35K | |
| 2022 | 562 | $26K | |
| 2023 | 306 | $14K | |
| 2024incomplete | 152 | $5K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 30% | 1,005 | 937 | $30K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 20% | 233 | 229 | $20K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 142 | 139 | $13K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 8.7% | 194 | 190 | $9K |
| 99152 | 7.6% | 165 | 162 | $8K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.1% | 116 | 114 | $7K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 5.4% | 25 | 25 | $5K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 5.2% | 57 | 56 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 18 | 14 | $2K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.6% | 36 | 36 | $2K |
| 1036F | <1% | 178 | 168 | $0.42 | |
| 3078F | <1% | 124 | 119 | $0.33 |
1 more codes
| 3074F | <1% | 81 | $0.02 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.